Page last updated: 2024-11-08

glutathionylspermidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID440772
CHEBI ID16613
SCHEMBL ID4359448
MeSH IDM0059291

Synonyms (14)

Synonym
l-gamma-glutamyl-l-cysteinyl-n-{3-[(4-aminobutyl)amino]propyl}glycinamide
CHEBI:16613
ts5 ,
C05730
n1-(gamma-l-glutamyl-l-cysteinyl-glycyl)-spermidine
33932-35-3
GLUTATHIONYLSPERMIDINE ,
DB03295
SCHEMBL4359448
Q3772542
5-[(1-{[2-({3-[(4-aminobutyl)amino]propyl}imino)-2-hydroxyethyl]imino}-1-hydroxy-3-sulfanylpropan-2-yl)imino]-5-hydroxynorvaline
DTXSID10955517
HY-148197
CS-0615851

Research Excerpts

Overview

Glutathionylspermidine is an intermediate formed in the biosynthesis of trypanothione. It is an essential metabolite in defence against chemical and oxidative stress.

ExcerptReferenceRelevance
"Glutathionylspermidine is an intermediate formed in the biosynthesis of trypanothione, an essential metabolite in defence against chemical and oxidative stress in the Kinetoplastida. "( ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides.
Chen, S; Coward, JK; Fairlamb, AH; Oza, SL; Wyllie, S, 2008
)
1.79
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
glutathione derivativeAny organonitrogen compound derived from the Glu-Cys-Gly tripeptide glutathione.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Glutathione metabolism013

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (9.09)18.7374
1990's11 (33.33)18.2507
2000's8 (24.24)29.6817
2010's11 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.88 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.83 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (8.57%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (91.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]